PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34302857-2	2021	We aimed to clarify whether BRCA2 BRC domain-associated mutation correlates with sensibility of platinum-based chemotherapy and survival in high-grade serous ovarian cancer(HGSOC).	Platinum	96-104	BRCA2 DNA repair associated	Homo sapiens	28-33	
34302857-6	2021	CONCLUSIONS: Somatic mutations in BRCA2 BRC domain confer a higher sensitivity to platinum-based therapy and are associated with a favourable survival in HGSOC.	Platinum	82-90	BRCA2 DNA repair associated	Homo sapiens	34-39